Search research articles
Contact Us
Filters
Showing results (21-30 of 46) with videos related to
Page
of 5
Sort By:
Plos Pathogens
|
April 19, 2012
In vivo suppression of HIV by antigen specific T cells derived from engineered hematopoietic stem cells
Scott G Kitchen, Bernard R Levin, Gregory Bristol, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
June 9, 2015
HIV-specific Immunity Derived From Chimeric Antigen Receptor-engineered Stem Cells
Anjie Zhen, Masakazu Kamata, Valerie Rezek, et al.
Plos One
|
March 20, 2012
Pre-clinical evaluation of a 213Bi-labeled 2556 antibody to HIV-1 gp41 glycoprotein in HIV-1 mouse models as a reagent for HIV eradication
Ekaterina Dadachova, Scott G Kitchen, Gregory Bristol, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
December 2, 2005
Serum levels of the homeostatic B cell chemokine, CXCL13, are elevated during HIV infection
Daniel P Widney, Elizabeth C Breen, W John Boscardin, et al.
Plos Pathogens
|
April 1, 2021
Robust CAR-T memory formation and function via hematopoietic stem cell delivery
Anjie Zhen, Mayra A Carrillo, Wenli Mu, et al.
Plos One
|
December 10, 2009
Engineering antigen-specific T cells from genetically modified human hematopoietic stem cells in immunodeficient mice
Scott G Kitchen, Michael Bennett, Zoran Galić, et al.
Plos Pathogens
|
August 30, 2021
Correction: Robust CAR-T memory formation and function via hematopoietic stem cell delivery
Anjie Zhen, Mayra A Carrillo, Wenli Mu, et al.
Current HIV Research
|
October 28, 2005
Rapid size dependent deletion of foreign gene sequences inserted into attenuated HIV-1 upon infection in vivo: implications for vaccine development
David G Brooks, Michael D Cohen, Beth D Jamieson, et al.
The Journal of Clinical Investigation
|
December 13, 2016
Targeting type I interferon-mediated activation restores immune function in chronic HIV infection
Anjie Zhen, Valerie Rezek, Cindy Youn, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 3, 2004
CD4 on CD8(+) T cells directly enhances effector function and is a target for HIV infection
Scott G Kitchen, Nicole R Jones, Stuart LaForge, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 46) with videos related to
Sort By:
Page
of 5
Plos Pathogens
|
April 19, 2012
In vivo suppression of HIV by antigen specific T cells derived from engineered hematopoietic stem cells
Scott G Kitchen, Bernard R Levin, Gregory Bristol, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
June 9, 2015
HIV-specific Immunity Derived From Chimeric Antigen Receptor-engineered Stem Cells
Anjie Zhen, Masakazu Kamata, Valerie Rezek, et al.
Plos One
|
March 20, 2012
Pre-clinical evaluation of a 213Bi-labeled 2556 antibody to HIV-1 gp41 glycoprotein in HIV-1 mouse models as a reagent for HIV eradication
Ekaterina Dadachova, Scott G Kitchen, Gregory Bristol, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
December 2, 2005
Serum levels of the homeostatic B cell chemokine, CXCL13, are elevated during HIV infection
Daniel P Widney, Elizabeth C Breen, W John Boscardin, et al.
Plos Pathogens
|
April 1, 2021
Robust CAR-T memory formation and function via hematopoietic stem cell delivery
Anjie Zhen, Mayra A Carrillo, Wenli Mu, et al.
Plos One
|
December 10, 2009
Engineering antigen-specific T cells from genetically modified human hematopoietic stem cells in immunodeficient mice
Scott G Kitchen, Michael Bennett, Zoran Galić, et al.
Plos Pathogens
|
August 30, 2021
Correction: Robust CAR-T memory formation and function via hematopoietic stem cell delivery
Anjie Zhen, Mayra A Carrillo, Wenli Mu, et al.
Current HIV Research
|
October 28, 2005
Rapid size dependent deletion of foreign gene sequences inserted into attenuated HIV-1 upon infection in vivo: implications for vaccine development
David G Brooks, Michael D Cohen, Beth D Jamieson, et al.
The Journal of Clinical Investigation
|
December 13, 2016
Targeting type I interferon-mediated activation restores immune function in chronic HIV infection
Anjie Zhen, Valerie Rezek, Cindy Youn, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 3, 2004
CD4 on CD8(+) T cells directly enhances effector function and is a target for HIV infection
Scott G Kitchen, Nicole R Jones, Stuart LaForge, et al.
Page
of 5